Riskpilot← Back to searchSign inGet full accessEuroapotheca Holding SWE AB
ABActiveOrg 5591434526Activities of holding companies · NACE 6421Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
-14% vs 2023
Equity ratio
90.2%
Financial strength
Net profit 2024
SEK -399,7M
-2622% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -398K | -14% |
| Net profit | SEK -399,7M | -2622% |
| Total assets | SEK 2,3B | -16% |
| Equity | SEK 2B | -17% |
| Employees | 0 | — |
Legal name
Euroapotheca Holding SWE AB
Org number
5591434526
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
3 januari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, äga och förvalta fast och lös egendom, tillhandahålla konsult- och managementtjänster avseende apoteksverksamhet, inklusive franschising av apotekskedjor och parallellimport av läkemedel samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −405 | −316 | −4 797 | −349 | −398 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −405 | −316 | −4 797 | −349 | −398 |
| Net financials | 45 126 | −495 231 | 262 344 | −14 339 | −399 348 |
| Profit before tax | 77 021 | −495 002 | 257 547 | −14 688 | −399 746 |
| Tax | −6 855 | −20 | −8 493 | −0 | −0 |
| Net profit | 70 166 | −495 022 | 249 054 | −14 688 | −399 746 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 408 635 | 2 882 696 | 2 674 386 | 2 673 974 | 2 255 611 |
| Equity | 2 724 430 | 2 229 408 | 2 478 462 | 2 463 774 | 2 035 684 |
| Long-term debt | 681 383 | 650 470 | 137 314 | 151 653 | 169 694 |
| Short-term debt | 2 822 | 2 818 | 58 610 | 58 547 | 50 233 |
| Total debt | 684 205 | 653 288 | 195 924 | 210 200 | 219 927 |
EBITDA margin
-39800000.0%
This company
15.8%
Market median
-251898834% vs market
20202024
Equity ratio
90.2%
This company
38.2%
Market median
+136% vs market
20202024
Return on equity
-19.6%
This company
18.4%
Market median
-207% vs market
20202024
Net profit margin
-39974600000.0%
This company
8.1%
Market median
-493513580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ME Authorized Recipient of Service | Authorized Recipient of Service | 2026 |
CK Chief Auditor | Chief Auditor | 2020 |
| Former (3) | ||
SK Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
AM Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2023 |
ME Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2026 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Former (5) | ||
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2021 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EUROAPOTHECA UAB LITAUEN
Euroapotheca Holding SWE AB (this company)Board members of Euroapotheca Holding SWE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Kristina Olsson | Chief Executive Officer | 0 companies |
| Anna Maria Möller Wide | Authorized Recipient of Service | 0 companies |
| Malin Elisabeth Kjellstenius | Authorized Recipient of Service | 0 companies |
| Marie Elisabet Hermansson Snellman | Authorized Recipient of Service | 0 companies |
| Cesar Kaysar Moré | Chief Auditor | 0 companies |
| Jurgis Gabrielius Rudgalvis | Board of Directors | 0 companies |
| Greta Koralioviené | Board of Directors | 0 companies |
| Justinas Miskinis | Board of Directors | 0 companies |
| Laimonas Devyzis | Chairman | 0 companies |
| Asta Juode¨kaite | Board of Directors | 0 companies |
| Robertas Cipkus | Board of Directors | 0 companies |
| Paulius Mencas | Chairman | 0 companies |
| Tomas Kibildis | Board of Directors | 0 companies |
| Matas Kasperavicius | Board of Directors | 0 companies |
| Vytautas Liatukas | Board of Directors | 0 companies |